James E. Rothman's most recent trade in PhenomeX Inc was a trade of 32,258 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 26, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
PhenomeX Inc | James E. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 32,258 | 32,258 | - | - | Stock Option (Right to Buy) | |
PhenomeX Inc | James E. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 19,565 | 163,810 | - | 0 | Common Stock | |
PhenomeX Inc | James E. Rothman | Director | Purchase of securities on an exchange or from another person at price $ 24.35 per share. | 08 Nov 2021 | 4,000 | 144,245 | - | 24.4 | 97,400 | Common Stock |
PhenomeX Inc | James E. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 4,900 | 4,900 | - | - | Stock Option (Right to Buy) | |
PhenomeX Inc | James E. Rothman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2021 | 1,400 | 140,245 | - | 0 | Common Stock | |
PhenomeX Inc | James E. Rothman | Director | Sale of securities on an exchange or to another person at price $ 52.75 per share. | 05 Mar 2021 | 140,000 | 138,845 | - | 52.8 | 7,385,000 | Common Stock |